PUBLISHER: Grand View Research | PRODUCT CODE: 1986349
PUBLISHER: Grand View Research | PRODUCT CODE: 1986349
The global exoskeleton market size was estimated at USD 590.02 million in 2025 and is projected to reach USD 1.79 billion by 2033, growing at a CAGR of 14.48% from 2026 to 2033. Rapidly growing global geriatric population, rising adoption rates of medical devices in different industries such as automobile, military, defense, and construction, and rising incidence of stroke are some of the key driving forces responsible for the exoskeleton market growth.
Furthermore, the growing incidence rate of spinal cord injuries (SCI) is expected to drive the demand across global markets. For instance, as per the National Spinal Cord Injury Statistical Center (NSCISC), in the U.S., 17,730 new SCIs are diagnosed annually, and approximately 291,000 live with SCIs.
Exoskeleton solutions are widely adopted across industries to support employee health and boost productivity, positioning them as a critical segment within the broader wearable robot market. Growing demand has led to emergence of several startups expertizing in exoskeleton technology and providing solutions for rehabilitation. Furthermore, constantly evolving exoskeleton industry is driving market players to devise innovative product development strategies to boost adoption over the forecast period. In January 2026, RoboCT introduced its lightweight GoGo Exoskeleton series at CES 2026, marking the company's expansion from clinical rehabilitation into consumer-focused daily mobility solutions. The 2.3 kg AI-powered wearable offers multi-mode, real-time adaptive support for activities such as walking, sitting, and balance assistance, targeting post-stroke recovery, neurodegenerative conditions, and everyday mobility needs.
Increasing prevalence of spinal cord injury is boosting the growth of the exoskeleton segment within the wearable robot market, as patients are increasingly recommended to use robotic wearable assistive devices to improve mobility and functional outcomes. RaThis has become major driver for adoption of exoskeleton by patients as well as healthcare providers. In September 2025, United Spinal Association reported that 250,000 to 390,000 people in the U.S. are living with spinal cord injury, with about 18,000 new cases each year, most often due to vehicle accidents and falls, and highlighted common secondary complications including depression, chronic pain, spasticity, pressure injuries, and bowel, bladder, and respiratory issues.
Some of the most common musculoskeletal injuries and disorders affecting the construction industry are occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI). For instance, as per WHO data estimates published in July 2022, approximately 1.71 billion individuals across the globe have musculoskeletal disorders that include neck pain, lower back pain, fractures, amputation, rheumatoid arthritis, and osteoarthritis. Similarly, in 2022, according to the U.S. Bureau of Labor Statistics, approximately 502,380 workers have occupation-related musculoskeletal disorders across several industries. These are some of the driving factors boosting adoption of exoskeleton solutions owing to benefits associated with exoskeleton technology, such as augmenting or assisting users' physical activity or capability, improving users' health & productivity, and reducing fatigue experienced by industrial workers.
Rapid technological advancements in the exoskeleton segment of the wearable robot market are expected to boost demand for robotic assistive devices across healthcare and industrial applications. Increasing popularity and growing adoption of exoskeletons by companies are expected to contribute to market growth. In addition, increasing adoption of exoskeletons in manufacturing sector, logistics, automotive, and construction is leading to a rise in penetration of exoskeletons, thereby fueling the market growth. In May 2025, Wandercraft initiated clinical trials of its AI powered Personal Exoskeleton, using NVIDIA AI and simulation tools to enable individuals with spinal cord injuries, stroke, and severe mobility impairments to stand and walk with real time adaptive support.
The trend of including exoskeletons in health insurance coverage is rising, making them more accessible to patients. This is particularly evident in countries such as Germany, where specific exoskeleton systems are recognized for insurance procurement. For instance, in November 2023, ReWalk Robotics Ltd. appreciated the Centers for Medicare & Medicaid Services (CMS) for officially publishing the Calendar Year 2024 Home Health Prospective Payment System Rule. This regulation, which was issued on November 1, 2023, and is set to be implemented starting from January 1, 2024, confirms the classification of exoskeletons under the Medicare brace benefit category.
Global Exoskeleton Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the exoskeleton market report on the basis of mobility, technology, extremity, end use and region: